How PKAN is Diagnosed: Genetics and Imaging

Diagnosing Pantothenate Kinase-Associated Neurodegeneration (PKAN) requires a combination of clinical observation, specialized brain imaging, and genetic confirmation. Because PKAN is so rare, the diagnostic process often involves ruling out other look-alike conditions before reaching a definitive answer ^[1].

The Role of Brain Imaging (MRI)

The most well-known clue for a PKAN diagnosis is a specific pattern on a brain MRI (Magnetic Resonance Imaging) known as the “eye-of-the-tiger” sign. This pattern appears in the globus pallidus, a part of the brain that helps coordinate movement ^[1].

• What it looks like: On certain MRI views (called T2-weighted images), the globus pallidus appears very dark because of iron buildup (hypointensity). In the center of this dark area, there is a small, bright spot of fluid and cell damage (hyperintensity) ^[1][2]. Specialists often use an additional sequence called SWI (Susceptibility-Weighted Imaging) to better visualize the iron.
• The “Eye” Can Change: While this sign is found in nearly 96% of classic PKAN cases, it is not permanent or universal ^[3]. In very young children or those with the “atypical” form, the bright center may not have developed yet. In advanced stages of the disease, the bright center can disappear as the entire area becomes dark with iron ^[2][4].
• Not Exclusive: Occasionally, other rare metabolic conditions or movement disorders can mimic this “eye” pattern. Because of this, an MRI alone is not enough for a final diagnosis; it must be confirmed with genetic testing ^[5][6].

Genetic Testing: The Gold Standard

To confirm PKAN, doctors look for changes (mutations) in the PANK2 gene. A definitive diagnosis is made when two pathogenic (disease-causing) or likely pathogenic variants are found—affecting both copies of the gene ^[1][7].

• Biallelic Variants: This term simply means both copies of the PANK2 gene (the one from the mother and the one from the father) have a mutation ^[1]. A “Variant of Uncertain Significance” (VUS) does not independently confirm PKAN.
• Comprehensive Testing: Most genetic tests “read” the gene to look for spelling errors. However, sometimes a piece of the gene is entirely missing. If a person has all the symptoms of PKAN but the first test only finds one mutation, doctors should order deletion and duplication analysis to check for these missing pieces ^[8].
• Family Testing: Doctors often test the parents (called segregation testing) to confirm that each parent carries one of the mutations and that the two variants are on opposite copies of the gene. This helps confirm the diagnosis and provides important information for other family members ^[9][3].

Understanding Inheritance (Autosomal Recessive)

PKAN follows an autosomal recessive inheritance pattern. This means that a person only develops the condition if they inherit a mutated PANK2 gene from both parents ^[10].

If both parents are carriers (meaning they each have one healthy gene and one mutated gene), for each pregnancy:

• There is a 25% chance the child will inherit two mutated genes and have PKAN.
• There is a 50% chance the child will inherit one mutated gene and be a healthy carrier, just like the parents.
• There is a 25% chance the child will inherit two healthy genes and not be a carrier ^[10][11].

Common “Look-Alikes” and Other Clues

Because many movement disorders look similar, doctors must distinguish PKAN from other types of Neurodegeneration with Brain Iron Accumulation (NBIA) ^[12].

• The NBIA Family: Conditions like PLAN (PLA2G6-associated), MPAN (C19orf12-associated), and BPAN (WDR45-associated) can all cause iron to build up in the brain. Each has slightly different symptoms and MRI patterns, and each requires testing of a different gene ^[12][13].
• Acanthocytosis: In a small minority of PKAN cases, a blood test might show acanthocytes, which are red blood cells with “spiky” or irregular shapes ^[14]. While finding these can help support a diagnosis, their absence does not rule out PKAN, as they are not a reliable standalone diagnostic test ^[15].

Molecular confirmation through genetic testing is the only way to be certain which specific NBIA disorder is present, which is essential for specialized care and future treatment planning ^[1].